Hexarelin

Research Phase

Hexarelin (Examorelin)

Category
Growth Hormone
Aliases
Examorelin, HEX
Administration
Subcutaneous injection, Intranasal (studied)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Increased appetite and a brief flushing sensation are commonly reported within the first days of use, consistent with its strong ghrelin receptor activity.

  2. 2

    3–4 Weeks

    Some users report early signs of improved recovery, though desensitization (a reduced response over time) is also commonly discussed within this window.

  3. 3

    5–7 Weeks

    Many users report cycling off around this point specifically to manage desensitization and cortisol-related effects.

  4. 4

    8–10 Weeks

    Continued or cyclical use is common; sustained daily use beyond this point is less frequently discussed given desensitization concerns.

  5. 5

    11–15 Weeks

    Available evidence does not describe outcomes for continuous use at this duration.

  6. 6

    16–20 Weeks

    Available evidence does not describe outcomes for continuous use at this duration.

  7. 7

    21–24 Weeks

    Available evidence does not describe outcomes for continuous use at this duration.

⚠️ Research context only. This is not medical advice and results are not guaranteed.